European Medicines Agency recommends additional measures to better manage risk of progressive multifocal leukoencephalopathy (PML) with Tysabri

Malta, 22 January 2010
Circular No. P02/2010
Login to Read more...
Associate : TheSYNAPSE
Publish Date: 23/01/2010
Section : Network Announcements
|